RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently needed. We developed a robust and simple, PCR-based host-blood transcriptomic signature, RISK6, for multiple applications: identifying individuals at risk of incident disease, as a screening test for subclinical or clinical tuberculosis, and for monitoring tuberculosis treatment. RISK6 utility was validated by blind prediction using quantitative real-time (qRT) PCR in seven independent cohorts. Prognostic performance significantly exceeded that of previous signatures discovered in the same cohort. Performance for diagnosing subclinical and clinical disease in HIV-uninfected and HIV-infected persons, assessed by area under the receiver-operating characteristic curve, exceeded 85%. As a screening test for tuberculosis, the sensitivity at 90% specificity met or approached the benchmarks set out in World Health Organization target product profiles for non-sputum-based tests. RISK6 scores correlated with lung immunopathology activity, measured by positron emission tomography, and tracked treatment response, demonstrating utility as treatment response biomarker, while predicting treatment failure prior to treatment initiation. Performance of the test in capillary blood samples collected by finger-prick was noninferior to venous blood collected in PAXgene tubes. These results support incorporation of RISK6 into rapid, capillary blood-based point-of-care PCR devices for prospective assessment in field studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
SEQC/MAQC-III Consortium (2014) · Nature Biotechnology · doi:10.1038/nbt.2957 · Cited by 983
Cited by
Applications of gene pair methods in clinical research: advancing precision medicine
Wu, C., Xie, X., Yang, X., Du, M., Lin, H., & Huang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00263-w · Cited by 10
“While FCGR1BP has not been directly identified as a PTB biomarker, its related genes, FCGR1A [149–152], FCGR1B [153, 154], and FCGR1C [155], have all been shown to be associated with PTB. KLF12 , a transcription factor belonging to the family of Kruppel-like factors, whose members have been shown…”
Metadata
- Authors
- Penn-Nicholson, A., Mbandi, S. K., Thompson, E., Mendelsohn, S. C., Suliman, S., Chegou, N. N., Malherbe, S. T., Darboe, F., Erasmus, M., Hanekom, W. A., Bilek, N., Fisher, M., Kaufmann, S. H. E., Winter, J., Murphy, M., Wood, R., Morrow, C., Van Rhijn, I., Moody, B., Murray, M., Andrade, B. B., Sterling, T. R., Sutherland, J., Naidoo, K., Padayatchi, N., Walzl, G., Hatherill, M., Zak, D., Scriba, T. J., The Adolescent Cohort Study team, Kafaar, F., Workman, L., Mulenga, H., Hughes, E. J., Xasa, O., Veldsman, A., Cloete, Y., Abrahams, D., Moyo, S., Gelderbloem, S., Tameris, M., Geldenhuys, H., Ehrlich, R., Verver, S., Geiter, L., The GC6-74 Consortium, Black, G. F., van der Spuy, G., Stanley, K., Kriel, M., Du Plessis, N., Nene, N., Roberts, T., Kleynhans, L., Gutschmidt, A., Smith, B., Loxton, A. G., Tromp, G., Tabb, D., Ottenhoff, T. H. M., Klein, M. R., Haks, M. C., Franken, K. L. M. C., Geluk, A., van Meijgaarden, K. E., Joosten, S. A., Boom, W. H., Thiel, B., Mayanja-Kizza, H., Joloba, M., Zalwango, S., Nsereko, M., Okwera, B., Kisingo, H., Parida, S. K., Golinski, R., Maertzdorf, J., Weiner, J., Jacobson, M., Dockrell, H., Smith, S., Gorak-Stolinska, P., Hur, Y.-G., Lalor, M., Lee, J.-S., Crampin, A. C., French, N., Ngwira, B., Ben-Smith, A., Watkins, K., Ambrose, L., Simukonda, F., Mvula, H., Chilongo, F., Saul, J., Branson, K., Mahomed, H., Hughes, E. J., Xasa, O., Veldsman, A., Downing, K., Mulenga, H., Abel, B., Bowmaker, M., Kagina, B., Chung, W. K., Sadoff, J., Sizemore, D., Ramachandran, S., Barker, L., Brennan, M., Weichold, F., Muller, S., Geiter, L., Kassa, D., Abebe, A., Mesele, T., Tegbaru, B., van Baarle, D., Miedema, F., Howe, R., Mihret, A., Aseffa, A., Bekele, Y., Iwnetu, R., Tafesse, M., Yamuah, L., Ota, M., Hill, P., Adegbola, R., Corrah, T., Antonio, M., Togun, T., Adetifa, I., Donkor, S., Andersen, P., Rosenkrands, I., Doherty, M., Weldingh, K., Schoolnik, G., Dolganov, G., Van, T., The SATVI Clinical and Laboratory Team, Arendsen, D., Africa, H., Baartman, V., Filander, E., Gwintsa, C., Mabwe, S., Makhethe, L., Moses, M., Onrust, R., van Rooyen, M., Steyn, M., Valley, H., The ScreenTB Consortium, Ahlers, P., van der Spuy, G., van Rensburg, I., Mutavhatsindi, H., Manngo, P., Stanley, K., Hiemstra, A., McAnda, S., Mendy, J., Gindeh, A., Mbayo, G., Trawally, E., Owolabi, O., Mayanja-Kizza, H., Nsereko, M., Namuganga, A.-R., Kizito, S. N., Mihret, A., Ayalew, S., Howe, R., Tarekegne, A., Tessema, B., Nepolo, E., Sheehama, J., Gunther, G., Diergaardt, A., Pazvakavambwa, U., Dockrell, H., Ottenhoff, T., Fat, E. T. K., Herdigein, S., Corstjens, P., Geluk, A., The AE-TBC Consortium, Kriel, M., van der Spuy, G., Loxton, A. G., Stanley, K., Kriel, B., Kotzé, L. A., Awoniyi, D. O., Maasdorp, E., Owolabi, O., Sillah, A., Mendy, J., Gindeh, A., Donkor, S., Togun, T., Ota, M., Mayanja-Kizza, H., Namuganga, A. R., Muzanye, G., Nsereko, M., Peters, P., van der Vyver, M., Amutenya, F. N., Nelongo, J. N., Monye, L., Sheehama, J. A., Iipinge, S., Crampin, A. C., Simukonda, F., Amberbir, A., Chilongo, F., Houben, R., Kassa, D., Gebrezgeabher, A., Mesfin, G., Belay, Y., Gebremichael, G., Alemayehu, Y., Howe, R., Mihret, A., Bekele, Y., Tessema, B., Yamuah, L., Ottenhoff, T. H. M., Geluk, A., Franken, K. L. M. C., Corstjens, P. L. A. M., Fat, E. M. T. K., de Dood, C. J., van der Ploeg-van Schip, J. J., Rosenkrands, I., Aagaard, C., Esterhuyse, M. M., Cliff, J. M., Dockrell, H. M., The RePORT Brazil Team, Cubillos-Angulo, J. M., Fukutani, K. F., Paixão, L., Khouri, R., Melo, S., Andrade, A., Rebouças-Silva, J., Malta, H., Queiroz, A. T. L., Rolla, V. C., Cavalcante, S., Durovni, B., Cordeiro-Santos, M., Kritski, A., Lapa e Silva, J. R., Figueiredo, M. C., Peruvian Household Contacts Cohort Team, Tamara, K. L., Tamara, K. L., León, S. R., Garcia, L. L., The CAPRISA IMPRESS team, Govender, D., Hassan-Moosa, R., Naidoo, A., Adams, R., Samsunder, N., & Lewis, L.
- Venue
- Scientific Reports
- Published
- 2020-05-25
- Volume
- 10
- Issue
- 1
- Pages
- 8629-8629
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W3027647317
- Cited by
- 177
- References
- 3
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. https://app.cochat.ai/papers/10.1038/s41598-020-65043-8
- The paper
- Penn-Nicholson, A., Mbandi, S. K., Thompson, E., Mendelsohn, S. C., Suliman, S., Chegou, N. N., Malherbe, S. T., Darboe, F., Erasmus, M., Hanekom, W. A., Bilek, N., Fisher, M., Kaufmann, S. H. E., Winter, J., Murphy, M., Wood, R., Morrow, C., Van Rhijn, I., Moody, B., . . . Lewis, L. (2020). RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Scientific Reports. https://doi.org/10.1038/s41598-020-65043-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.